Recent advances in breast cancer genetics.
作者信息
Pasche Boris
机构信息
Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Cancer Genetics Program, Chicago, IL 60611, USA.
出版信息
Cancer Treat Res. 2008;141:1-10. doi: 10.1007/978-0-387-73161-2_1.
Abstract
摘要
相似文献
1
Recent advances in breast cancer genetics.乳腺癌遗传学的最新进展
Cancer Treat Res. 2008;141:1-10. doi: 10.1007/978-0-387-73161-2_1.
2
The genetics of inherited breast cancer.遗传性乳腺癌的遗传学
J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):365-76. doi: 10.1023/a:1018779830743.
3
BRCA1 and BRCA2--breast cancer susceptibility genes.BRCA1和BRCA2——乳腺癌易感基因。
J Cancer Res Clin Oncol. 2000 Sep;126(9):487-96. doi: 10.1007/s004320000140.
4
Current perspectives on BRCA1- and BRCA2-associated breast cancers.BRCA1和BRCA2相关乳腺癌的当前观点
Intern Med J. 2001 Aug;31(6):349-56. doi: 10.1046/j.1445-5994.2001.00075.x.
5
Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk.遗传易感性与乳腺癌：BRCA1/2相关乳腺癌风险的调节因素
Environ Mol Mutagen. 2002;39(2-3):228-34. doi: 10.1002/em.10050.
6
Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?对大型基因组重排的搜索是否会影响BRCAPRO携带者预测？
J Clin Oncol. 2007 Jun 20;25(18):2632-4; author reply 2634-5. doi: 10.1200/JCO.2007.11.4330.
7
BRCA1 and BRCA2 in breast cancer predisposition and recombination control.乳腺癌易感性及重组控制中的BRCA1和BRCA2
J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):237-46. doi: 10.1023/B:JOMG.0000048771.93906.3e.
8
BRCA1 and BRCA2.乳腺癌1号基因和乳腺癌2号基因
Curr Biol. 2000 Aug 24;10(16):R582. doi: 10.1016/s0960-9822(00)00646-1.
9
Genetics of breast cancer: contribution of BRCA1/2 genes alterations to hereditary predisposition.乳腺癌的遗传学：BRCA1/2基因改变对遗传性易感性的影响。
Vojnosanit Pregl. 2012 Aug;69(8):700-6.
10
BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.BRCA1和BRCA2——乳腺癌遗传学的最新进展及影响：临床视角
Clin Genet. 2014 Jan;85(1):1-4. doi: 10.1111/cge.12291. Epub 2013 Oct 25.
引用本文的文献
1
Screening, diagnosis and genetic study of breast cancer patients in Pakistan.巴基斯坦乳腺癌患者的筛查、诊断及基因研究
Pak J Med Sci. 2020 Jan-Feb;36(2):16-20. doi: 10.12669/pjms.36.2.1059.
2
RAP80, ubiquitin and SUMO in the DNA damage response.DNA损伤反应中的RAP80、泛素和小泛素样修饰蛋白
J Mol Med (Berl). 2017 Aug;95(8):799-807. doi: 10.1007/s00109-017-1561-1. Epub 2017 Jul 5.
3
The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women.五个 DNA 修复基因的七个常见多态性与中国北方女性乳腺癌风险的关系。
PLoS One. 2014 Mar 18;9(3):e92083. doi: 10.1371/journal.pone.0092083. eCollection 2014.
4
Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.BRCA1 启动子甲基化谱在遗传性和散发性乳腺癌中的汉族人群。
Med Oncol. 2012 Sep;29(3):1561-8. doi: 10.1007/s12032-011-0100-0. Epub 2011 Nov 11.
5
TGFBR1 signaling and breast cancer.TGFBR1 信号转导与乳腺癌。
J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):89-95. doi: 10.1007/s10911-011-9216-2. Epub 2011 Apr 5.
6
The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.乳腺癌患者心碎综合征的治疗：曲妥珠单抗与心力衰竭
Exp Clin Cardiol. 2009 Fall;14(3):e62-7.
7
Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.候选低外显率乳腺癌易感基因的生物学过程、特性及分子连接图
BMC Med Genomics. 2008 Dec 18;1:62. doi: 10.1186/1755-8794-1-62.
本文引用的文献
1
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects.BRCA1和BRCA2基因缺陷的小鼠模型：过去的经验教训、当前的认识及未来展望。
Oncogene. 2006 Sep 25;25(43):5885-97. doi: 10.1038/sj.onc.1209871.
2
Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study.BRCA1和BRCA2突变携带者的降低风险手术、筛查及化学预防措施：一项前瞻性队列研究。
Clin Genet. 2006 Sep;70(3):198-206. doi: 10.1111/j.1399-0004.2006.00665.x.
3
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.乳腺癌高危家族中BRCA1、BRCA2、CHEK2和TP53的突变谱。
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
4
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution.乳腺癌1号基因（BRCA1）：细胞周期检查点、基因不稳定、DNA损伤反应与癌症演变
Nucleic Acids Res. 2006 Mar 6;34(5):1416-26. doi: 10.1093/nar/gkl010. Print 2006.
5
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
6
Genetic/familial high-risk assessment: breast and ovarian.遗传/家族性高危评估：乳腺癌和卵巢癌。
J Natl Compr Canc Netw. 2006 Feb;4(2):156-76. doi: 10.6004/jnccn.2006.0016.
7
Is TGFBR1*6A really associated with increased risk of cancer?转化生长因子β受体1*6A真的与癌症风险增加相关吗？
J Clin Oncol. 2005 Oct 20;23(30):7743-4; author reply 7744-6. doi: 10.1200/JCO.2005.02.9108.
8
Somatic acquisition and signaling of TGFBR1*6A in cancer.癌症中TGFBR1*6A的体细胞获得与信号传导
JAMA. 2005 Oct 5;294(13):1634-46. doi: 10.1001/jama.294.13.1634.
9
Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.对转化生长因子-β信号通路变异体进行联合基因评估可能预测乳腺癌风险。
Cancer Res. 2005 Apr 15;65(8):3454-61. doi: 10.1158/0008-5472.CAN-04-2961.
10
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.MDM2启动子中的单核苷酸多态性会减弱p53肿瘤抑制通路，并加速人类肿瘤的形成。
Cell. 2004 Nov 24;119(5):591-602. doi: 10.1016/j.cell.2004.11.022.
Zotero 插件